课题基金 / 基金详情

神经轴突导向分子Plexin B2负向调控自发性生发中心的机制及在干预系统性红斑狼疮中的验证研究

批准号:
82071744
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
张晋渝
学科分类:
自身免疫性疾病
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
张晋渝

项目摘要

结项摘要

张晋渝的其他基金

相似基金

相关文献

中文摘要
有效调控自发性生发中心(Spt-GC)维持外周B细胞稳态是干预系统性红斑狼疮(SLE)的新方向。本项目前期发现,在无外来抗原刺激的免疫稳态下,Spt-GC B细胞高表达轴突导向分子Plexin B2,敲除该分子后Spt-GC B细胞比例显著增加,我们推测其对Spt-GC的负向调控作用,可能成为干预SLE的新靶点。本项目将研究稳态下,Plexin B2对Spt-GC形成、凋亡、分化、功能等影响,阐明其对Spt-GC的负向调控机制;构建条件性敲除小鼠,鉴定并验证Plexin B2的配体及二者的结合方式;测序分析Spt-GC B细胞内Plexin B2下游关键分子,探究其与Plexin B2在调控Spt-GC中的关系;验证Plexin B2与配体负向调控Spt-GC在干预SLE中的应用。本研究将为Plexin B2通过负向调控Spt-GC维持B细胞稳态,成为干预SLE的新靶点奠定理论与应用基础。
英文摘要
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the loss of tolerance to self-nuclear antigens. Robust spontaneous germinal center (Spt-GC) is one of the major abnormal sites contributing to the pathogenesis of SLE. Strict control of Spt-GC is an important way to maintain the homeostasis of peripheral B cells and prevent SLE. In recent years, B cell-centered immune intervention has become a new hot spot. An early microarray screening study found that an axon guiding molecule Plexin B2 was highly expressed on T cell-dependent germinal center, and the output and affinity maturation of plasma cells were impaired after knockout of the molecule. In the present project, we found that Plexin B2 was also highly expressed on Spt-GC under steady state, however, Spt-GC B cells were increased after Plexin B2 knockout, suggesting a negative regulatory effect on Spt-GC and B cell homeostasis of Plexin B2. In this project, we will first investigate the effects of Plexin B2 on the formation, apoptosis and function of Spt-GC, then explore its ligand, interaction mode and molecular mechanism, finally observe the intervention effect on SLE mice. To elucidate the role and mechanism of Plexin B2 and its ligand in the regulation of Spt-GC will provide a theoretical basis for the treatment for SLE.
有效调控自发性生发中心(Spt-GC)维持外周B细胞稳态是干预自身免疫性疾病的新方向。本项目发现,神经轴突导向分子PlxnB2及其配体Sema4C均在Spt-GC B细胞上高表达。B细胞上特异性缺失PlxnB2或Sema4C都将导致Spt-GC B细胞显著增加。RNA测序及自身抗体芯片结果发现,PlxnB2或Sema4C缺失的Spt-GC B细胞具有不同的基因表达谱和自身抗体库。从机制上,PlxnB2-Sema4C以in Trans的作用方式抑制mTORC1向B细胞传递信号。当B细胞中的PlxnB2-Sema4C轴被敲除时,脾脏浆细胞会显著增加,并且IMQ诱导的银屑病样疾病会显著加剧。综上所述,我们发现了稳态下,生发中心内的一种新的跨膜PlxnB2-Sema4C相互作用,其对维持外周B细胞耐受具有重要作用。明确PlxnB2-Sema4C轴的特性,有助于理解和治疗B细胞相关的自身免疫性疾病。
GSK-3β调控Tscm细胞分化在胃癌中的作用及机制研究
胃癌外周血中Tscm细胞的分化、趋化及在胃癌免疫中的前瞻性研究
国内基金
海外基金